MARATTO

article · Journal of Drug Delivery Science and Technology

Fabrication of dissolving PVP/Eudragit microneedles loaded with febuxostat-chitosan nanoparticles for promoting gouty arthritis with hyperuricemia via Nrf2/NF-κB/NLRP3 and VEGF pathways

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Gout, Hyperuricemia, Uric Acid
  • Advancements in Transdermal Drug Delivery
  • Inflammasome and immune disorders

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.jddst.2026.108188

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.